What types of peptides does Thinheal supply?

Thinheal supplies generic peptide APIs, therapeutic peptides, GLP-1 analogues such as Semaglutide (CAS 910463-68-2), GLP-2 analogues, other gastrointestinal peptides, other therapeutic peptide APIs and cosmetic peptides for skin-care formulations.

Does Thinheal offer custom peptide development and CDMO services?

Yes. Thinheal provides project-based contract research and development, contract manufacturing and sales support, covering custom peptide development, process optimization, scale-up and commercial API supply through to formulation development.

What is Thinheal's production capacity?

Thinheal operates an R&D center and a production base in Hangzhou, China. Total production capacity for chemically synthesized peptides has reached the multi-ton level.

What documentation can buyers expect?

Each shipment is accompanied by batch analytical data such as a Certificate of Analysis. Additional documents required for supplier qualification or regulatory filings can be scoped with the sales and technical team for each project.

How do international buyers contact the right sales team?

Thinheal runs regional sales desks for USA & Europe, Russia & CIS & Europe, Asia, and the Middle East & East Asia. Buyers can also email info@thinheal.com or call +86 0571-86758863.

High-Quality Eptifibatide CAS 188627-80-7 - High-Quality China Suppliers and Factory for Platelet Aggregation Inhibition Manufacturer, Service

1 / 1

High-Quality Eptifibatide CAS 188627-80-7 - High-Quality China Suppliers and Factory for Platelet Aggregation Inhibition Manufacturer, Service

Eptifibatide is a highly effective competitive antagonist of activated platelet glycoprotein IIb/IIIa receptors, which are crucial for platelet aggregation. By binding to these receptors, Eptifibatide inhibits the binding of fibrinogen to other adhesion molecules, thereby preventing platelet activation and reducing aggregation. This mechanism plays a vital role in minimizing the risk of thrombosis, a primary cause of heart attacks and various cardiovascular complications. As a reliable product supplied by trusted suppliers in China, our Eptifibatide is manufactured in a state-of-the-art factory, ensuring high quality and efficacy for cardiovascular health management

Send Inquiry

Product Description

Eptifibatide is a competitive antagonist of activated platelet glycoprotein IIb/IIIa receptors, which play a key role in platelet aggregation. By binding to this receptor, Eptifibatide effectively inhibits the binding of fibrinogen to other adhesion molecules, thereby preventing platelet activation and aggregation. This action significantly reduces the risk of thrombosis, which is the main cause of heart attacks and other cardiovascular events.

Therapeutic Areas

A revolutionary antiplatelet therapy

Eptifibatide, a breakthrough cyclic heptapeptide, is setting a new standard for the treatment of acute coronary syndrome and other cardiovascular diseases. With its unique mechanism of action and proven efficacy, Eptifibatide is expected to become an important part of modern antiplatelet therapy.

Clinical efficacy

Numerous clinical trials have demonstrated the effectiveness of eptifibatide in reducing adverse cardiovascular events. Patients who received eptifibatide in combination with standard antiplatelet therapy had significantly reduced rates of myocardial infarction and the need for urgent revascularization procedures. Eptifibatide has a rapid onset of action and a short half-life, making it an ideal choice for emergency use, allowing for rapid intervention in critical situations.

Security Profile

The safety and tolerability of eptifibatide have been extensively studied. While all antiplatelet therapies carry some risk of bleeding, eptifibatide is well characterized and generally well tolerated by patients. Close monitoring of patients receiving eptifibatide ensures that any potential adverse effects are addressed promptly, making it a reliable option for healthcare providers.

Outlook & Development

Indications and Usage

Eptifibatide is indicated for patients with acute coronary syndrome, including those undergoing percutaneous coronary intervention (PCI). The drug is administered intravenously, allowing precise dosing and rapid adjustment based on the patient’s clinical condition. Eptifibatide is flexible in dosing and is suitable for a variety of clinical scenarios, from the emergency department to the intensive care unit.

In Conclusion

As the field of cardiology continues to advance, eptifibatide has become an important tool in the fight against cardiovascular disease. Its innovative mechanism of action, proven clinical efficacy, and favorable safety profile make it an indispensable and valuable resource for medical professionals committed to improving patient outcomes. By incorporating eptifibatide into treatment regimens, clinicians can enhance the management of acute coronary syndromes and provide optimal treatment for patients.

In short, eptifibatide is more than just an antiplatelet drug, it is a transformative therapy that represents the future of cardiovascular treatment. Eptifibatide can effectively inhibit platelet aggregation and reduce the risk of thrombotic events, and will surely play a key role in the ongoing fight against heart disease. Eptifibatide, embrace the future of antiplatelet therapy - the perfect combination of innovation and patient care.

Frequently Asked Questions

What is Eptifibatide?

Eptifibatide is a breakthrough cyclic heptapeptide and a competitive antagonist of activated platelet glycoprotein IIb/IIIa receptors, fundamentally used to prevent platelet aggregation.

How does Eptifibatide work in the body?

By binding to the glycoprotein IIb/IIIa receptor, Eptifibatide effectively inhibits the binding of fibrinogen to other adhesion molecules, thereby preventing platelet activation and aggregation.

What are the main indications for using Eptifibatide?

It is primarily indicated for patients with acute coronary syndrome, including those who are undergoing percutaneous coronary intervention (PCI).

How is Eptifibatide administered?

The drug is administered intravenously. This method allows for precise dosing and rapid adjustments based on a patient's real-time clinical condition.

What are the clinical benefits of this therapy?

Clinical trials show it significantly reduces rates of myocardial infarction and the need for urgent revascularization. It also features a rapid onset of action and a short half-life, making it ideal for emergencies.

Is Eptifibatide considered safe?

Yes, while all antiplatelet therapies carry some risk of bleeding, Eptifibatide is well characterized and generally well tolerated. Close monitoring ensures any adverse effects are addressed promptly.

High-Quality Eptifibatide CAS 188627-80-7 - High-Quality China Suppliers and Factory for Platelet Aggregation Inhibition Manufacturer, Service

Product Description

Related Products

Custom Cargrilintide CAS 1415456-99-3 - High-Quality Peptide from China Suppliers and Factory Quotes, Service

High-Quality Mots-C Peptide 16 Amino Acids - China Suppliers and Factory for Metabolic Regulation and Insulin Sensitivity Quotes, Pricelist

Custom Bremelanotide/PT141 CAS 189691-06-3 - China Suppliers & Factory for Melanocortin Receptor Agonist Quotes, Service

High-Quality Survodutide CAS 2805997-46-8 - Premium China Suppliers & Factory for High-Quality Peptides Quotes, Pricelist

High-Quality Orforglipron CAS 2212020-52-3 - Top China Suppliers & Factory for High-Quality Pharmaceutical Ingredients Manufacturers, Service

Custom Thymalin CAS 63958-90-7 - China Suppliers Factory for Immune System Support & Polypeptide Therapy Manufacturers, Service

Custom Dulaglutide CAS 923950-08-7 - Leading China Suppliers and Reliable Factory for High-Quality Production Manufacturers, Quotes

High-Quality Copper Tripeptide (GHK-Cu) CAS:89030-95-5 - Premium Quality from China Suppliers & Factory Manufacturers, Service

High-Quality Semax Peptide CAS 80714-61-0 - Top China Suppliers & Factory for Enhanced CNS Effects Manufacturers, Pricelist

Custom BPC-157 CAS:137525-51-0 - High-Quality Tissue Repair Peptide from China Suppliers and Factory Manufacturer, Manufacturers